The following data is part of a premarket notification filed by Asuragen, Inc. with the FDA for Rnaretain.
| Device ID | K113420 |
| 510k Number | K113420 |
| Device Name: | RNARETAIN |
| Classification | Tissue Rna Preservative For Collection, Storage, And Transportation |
| Applicant | ASURAGEN, INC. 2150 WOODWARD ST. SUITE 100 Austin, TX 78744 -1840 |
| Contact | Luc Van Hove |
| Correspondent | Luc Van Hove ASURAGEN, INC. 2150 WOODWARD ST. SUITE 100 Austin, TX 78744 -1840 |
| Product Code | OZF |
| CFR Regulation Number | 866.4070 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2011-11-18 |
| Decision Date | 2012-03-16 |
| Summary: | summary |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00863840000285 | K113420 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RNARETAIN 77209982 3689865 Live/Registered |
Asuragen, Inc. 2007-06-19 |